XML 82 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

Warrants | 12 Months Ended
--- | ---
Jan. 31, 2026
Equity [Abstract] |
Warrants | Warrants Equity-Classified Warrants From 2019 to 2023, the Company issued warrants to purchase an aggregate of 1.6 million shares of common stock with a weighted-average exercise price of $2.60. All warrants expire 10 years from the date of gran t. As of January 31, 2026, none of these equity-classified warrants had vested or been exercised. Liability-Classified Warrants The warrant liabilities are included in other noncurrent liabilities in the consolidated balance sheets. The fair value of the warrants is remeasured at the end of every reporting period, with changes in fair value during the period recorded as a component of other expense (income), net in the consolidated statements of operations. Common Stock Warrant In April 2020, the Company issued a warrant to purchase 60,000 shares of common stock at an exercise price of $1.16 per share. At January 31, 2026 and January 31, 2025, the warrant was recorded at fair value of approximately $0.5 million and $0.8 million, respectively. The warrant expires in April 2030. The fair value of the common stock warrant was estimated using the BSM option-pricing model with the following assumptions:
| January 31, |  | January 31,
| 2026 |  | 2025
Expected term (years) | 4.24 |  |  | 5.24 |
Expected volatility | 55.00 | % |  | 54.40 | %
Risk-free interest rate | 3.70 | % |  | 4.42 | %
Expected dividends | — | % |  | — | %
Fair value of common stock | $ | 8.68 |  |  | $ | 14.04 |
Series G Warrant At January 31, 2026 and January 31, 2025, a warrant to purchase 251,750 shares of the Company’s common stock (the “Series G Warrant”) was outstanding at a fair value of $1.5 million and $2.7 million, respectively. The Series G Warrant was originally exercisable for shares of Series G redeemable convertible preferred stock, which automatically converted into common stock upon the completion of the Company’s IPO. The Series G Warrant is immediately exercisable and expires five years from the effective date of an IPO. The fair value of the Series G Warrant was estimated using the BSM option-pricing model with the following assumptions:
| January 31, |  | January 31,
| 2026 |  | 2025
Expected term (years) | 4.86 |  |  | 5.50 |
Expected volatility | 55.00 | % |  | 53.40 | %
Risk-free interest rate | 3.75 | % |  | 4.42 | %
Expected dividends | — | % |  | — | %
Fair value of common stock | $ | 8.68 |  |  | $ | 16.15 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Stockholders' Equity Note, Liability Classified Warrants or Rights + References No definition available. + Details
Name: | wlth_ScheduleOfStockholdersEquityNoteLiabilityClassifiedWarrantsOrRightsTextBlock
Namespace Prefix: | wlth_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration